To evaluate the anti-metastatic and the anti-tumor effect of AX09 in a clinically meaningful setting, transgenic BALB-neuT mice that spontaneously develop mammary tumors and lung metastases were vaccinated with AX09 or MS2 wt six times over a 30 week period of time (Figure 6A). This evidence concerns the gene ADAM8 and breast cancer.